Federal health officials will use new regulatory authority to monitor prescription drug usage by millions Medicare participants for potential safety problems with medicines and medical devices.
The Food and Drug Administration has been under increasing pressure to develop a comprehensive drug surveillance system since the painkiller Vioxx was pulled from the market in 2004 after it was linked to increased risk of stroke and heart attack.
New regulations announced Thursday by the Health and Human Services Department will enable federal agencies, states and academic researchers to screen Medicare claims data.
Personally identifying information will …
Inga kommentarer:
Skicka en kommentar